DOI QR코드

DOI QR Code

MicroRNAs in Human Diseases: From Lung, Liver and Kidney Diseases to Infectious Disease, Sickle Cell Disease and Endometrium Disease

  • Ha, Tai-You (Department of Immunology, Chonbuk National University Medical School)
  • Received : 2011.09.23
  • Accepted : 2011.10.15
  • Published : 2011.12.31

Abstract

MicroRNAs (miRNAs) are a class of naturally occurring small non-coding RNAs of about 22 nucleotides that have recently emerged as important regulators of gene expression at the posttranscriptional level. Recent studies provided clear evidence that microRNAs are abundant in the lung, liver and kidney and modulate a diverse spectrum of their functions. Moreover, a large number of studies have reported links between alterations of miRNA homeostasis and pathological conditions such as infectious diseases, sickle cell disease and endometrium diseases as well as lung, liver and kidney diseases. As a consequence of extensive participation of miRNAs in normal functions, alteration and/or abnormalities in miRNAs should have importance in human diseases. Beside their important roles in patterning and development, miRNAs also orchestrated responses to pathogen infections. Particularly, emerging evidence indicates that viruses use their own miRNAs to manipulate both cellular and viral gene expression. Furthermore, viral infection can exert a profound impact on the host cellular miRNA expression profile, and several RNA viruses have been reported to interact directly with cellular miRNAs and/or to use these miRNAs to augment their replication potential. Here I briefly summarize the newly discovered roles of miRNAs in various human diseases including infectious diseases, sickle cell disease and enodmetrium diseases as well as lung, liver and kidney diseases.

Keywords

References

  1. Tili E, Michaille JJ, Calin GA: Expression and function of micro-RNAs in immune cells during normal or disease state. Int J Med Sci 5;73-79, 2008.
  2. Slaby O, Svoboda M, Michalek J, Vyzula R: MicroRNAs in colorectal cancer: translation of molecular biology into clinical application. Mol Cancer 8;102, 2009 https://doi.org/10.1186/1476-4598-8-102
  3. Small EM, Olson EN: Pervasive roles of microRNAs in cardiovascular biology. Nature 469;336-342, 2011. https://doi.org/10.1038/nature09783
  4. Ha TY: MicroRNAs in human diseases: from cancer to cardiovascular disease. Immune Netw 11;135-154, 2011. https://doi.org/10.4110/in.2011.11.3.135
  5. Ha TY: MicroRNAs in human diseases: from autoimmune diseases to skin, psychiatric and neurodegenerative diseases. Immune Netw 11;227-244, 2011 https://doi.org/10.4110/in.2011.11.5.227
  6. Ha TY: The role of microRNAs in regulatory T cells and in the immune response. Immune Netw 11;11-41, 2011. https://doi.org/10.4110/in.2011.11.1.11
  7. O'Connell RM, Rao DS, Chaudhuri AA, Baltimore D: Physiological and pathological roles for microRNAs in the immune system. Nat Rev Immunol 10;111-122, 2010. https://doi.org/10.1038/nri2708
  8. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW, Jing Q: Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 31;659-666, 2010. https://doi.org/10.1093/eurheartj/ehq013
  9. Miller BH, Wahlestedt C: MicroRNA dysregulation in psychiatric disease. Brain Res 1338;89-99, 2010. https://doi.org/10.1016/j.brainres.2010.03.035
  10. Belver L, de Yébenes VG, Ramiro AR: MicroRNAs prevent the generation of autoreactive antibodies. Immunity 33; 713-722, 2010. https://doi.org/10.1016/j.immuni.2010.11.010
  11. Guo H, Ingolia NT, Weissman JS, Bartel DP: Mammalian microRNAs predominantly act to decrease target mRNA levels. Nature 466;835-840, 2010. https://doi.org/10.1038/nature09267
  12. Perera JR, Ray A: MicroRNAs in the search for understanding human diseases. Biodrug 21;97-104, 2007. https://doi.org/10.2165/00063030-200721020-00004
  13. Dai R, Ahmed SA: MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res 157;163-179, 2011. https://doi.org/10.1016/j.trsl.2011.01.007
  14. Lu M, Zhang Q, Deng M, Miao J, Guo Y, Gao W, Cui Q: An analysis of human microRNA and disease associations. PLoS One 3;e3420, 2008. https://doi.org/10.1371/journal.pone.0003420
  15. Tomankova T, Petrek M, Kriegova E: Involvement of microRNAs in physiological and pathological process in the lung. Resp Res 11;159-169, 2010. https://doi.org/10.1186/1465-9921-11-159
  16. van Pottelberge G, Mestadgh P, Bracke KR, Thas GF, Van Dume YMTA, Joos GF, Vandesompele J, Brusselle GG: MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary diseases. Am J Respir Crit Care Med 183;898-906, 2011. https://doi.org/10.1164/rccm.201002-0304OC
  17. Caramori G, Casolari P, Cavallesco GN, Giuffre S, Adeock I, Papi A: Mechanisms involved in lung cancer development in COPD. Int J Biochem Cell Biol 43;1030-1044, 2011 https://doi.org/10.1016/j.biocel.2010.08.022
  18. Jopling CI, Yi M, Lancaster AM, Lemon SM, Sarnow P: Modulation of hepatitis C virus RNA abundance by a liver- specific microRNA. Science 309;1577-1581, 2005. https://doi.org/10.1126/science.1113329
  19. Chen XM: MicroRNA signatures in liver diseases. World J Gastroenterol 15;1665-1672, 2009. https://doi.org/10.3748/wjg.15.1665
  20. Trang P, Weidhaas JB, Slack FJ: MicroRNAs as potential cancer therapeutics. Oncogene 27;S52-S57, 2009.
  21. Li LM, Hou DX, Guo YL, Yang JW, Liu Y, Zhang CY, Zen K: Role of microRNA-214-targeting phosphatase and tensin homolog in advanced glycation end product-induced apoptosis delay in monocytes. J Immunol 186; 2552-2560, 2011. https://doi.org/10.4049/jimmunol.1001633
  22. Lu LF, Liston A: MicroRNA in the immune system, microRNA as an immune system. Immunology 127;291-298, 2009. https://doi.org/10.1111/j.1365-2567.2009.03092.x
  23. Lu LF, Liston A: MicroRNA in the immune system, microRNA as an immune system. Immunology 127;291-298, 2009. https://doi.org/10.1111/j.1365-2567.2009.03092.x
  24. Cullen BR: Viruses and microRNAs. Nat Genet 38;S25-S30, 2006. https://doi.org/10.1038/ng1793
  25. Pallante P, Visone R, Croce CM, Fusco A: Deregulation of microRNA expression in follicular cell-derived human thyroid carcinomas. Endocrine-Related Cancer 17;F91-F104, 2010. https://doi.org/10.1677/ERC-09-0217
  26. Calin GA, Croce CM: MicroRNA signatures in human cancers. Nature Rev Cancer 6;857-866, 2006. https://doi.org/10.1038/nrc1997
  27. Shenouda SK, Alahari SK: MicroRNA function in cancer: oncogene or a tumor suppressor? Cancer Metasis Rev 28; 369-378, 2009. https://doi.org/10.1007/s10555-009-9188-5
  28. Bartel DP: MicroRNAs: Genomics, biogenesis, mechanisms, and funtion. Cell 116;281-297, 2004. https://doi.org/10.1016/S0092-8674(04)00045-5
  29. Kim VN, Han J, Siomi MC: Biogenesis of small RNAs in animals. Nature Rev Mol Cell Biol 10;126-139, 2009. https://doi.org/10.1038/nrm2632
  30. Kim VN: Small RNAs: Classification, biogenesis, and function. Mol Cells 19;1-15, 2005. https://doi.org/10.1016/j.molcel.2005.05.026
  31. Boyd SD: Everything you wanted to know about small RNA but were afraid to ask. Lab Invest 88;569-578, 2008. https://doi.org/10.1038/labinvest.2008.32
  32. Rodriquez A, Crffiths-Jones S, Ashurst JL, Bradely A: Identification of mammalian microRNA host genes and transcription units. Genome Res 14;1902- 1910, 2004. https://doi.org/10.1101/gr.2722704
  33. Sonkoly E, Pivarcsi A: Advances in microRNAs: implications for immunity and inflammatory diseases. J Cell Mol Med 13;24-38, 2009.
  34. Hunsberger JG, Austin DR, Chen G, Manji HK: MicroRNAs in mental health: from biological underpinnings to potential therapies. Neuromol Med 11;173-182, 2009. https://doi.org/10.1007/s12017-009-8070-5
  35. Sato T, Liu X, Melson A, Nakanishi M, Kanaji N, Wang X, Kim M, Li Y, Sun J, Michalski J, Patil A, Basma H, Holz O, Magnussen H, Rennard SI: Reduced miR-146a increases prostaglandin E2 in chronic obstructive pulmonary disease fibroblast. Am J Repir Crit Care Med 182;1020-1029, 2010. https://doi.org/10.1164/rccm.201001-0055OC
  36. Schembri F, Sridhar S, Perdomo C, Gustafson AM, Zhang X, Ergun A, Lu J, Liu G, Zhang X, Bowers J, Vaziri C, Ott K, Sensinger K, Collins JJ, Brody JS, Getts R, Lenburg ME, Spira A: MicroRNAs as modulators of smoking-induced gene expression changes in human airway epithelium. Proc Natl Acad Sci U S A 106;2319-2324, 2009. https://doi.org/10.1073/pnas.0806383106
  37. Pandit KV, Corcoran D, Yousef H, Yarlagadda M, Tzouvelekis A, Gibson KF, Konishi K, Yousem SA, Singh M, Handley D, Richards T, Selman M, Watkins SC, Pardo A, Ben-Yehudah A, Bouros D, Eickelberg O, Ray P, Benos PV, Kaminski N: Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 182;220-229, 2010. https://doi.org/10.1164/rccm.200911-1698OC
  38. Liu G, Frigger A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminiski N, Abraham E: miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207;1589-1597, 2010. https://doi.org/10.1084/jem.20100035
  39. Liu G, Frigger A, Yang Y, Milosevic J, Ding Q, Thannickal VJ, Kaminiski N, Abraham E: miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med 207;1589-1597, 2010. https://doi.org/10.1084/jem.20100035
  40. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG, Greene CM: miR-126 is downregulated in cystic fibrosis airway epitherlial cells and regualtes TOM1 expression. J Immunol 184;1702-1709, 2010. https://doi.org/10.4049/jimmunol.0902669
  41. Miranda RC, Pietrzykowski AZ, Tang Y, Sathyan P, Mayfield D, Keshavarzian A, Sampson W, Hereld D: MicroRNAs: Master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res 34;1-13, 2010. https://doi.org/10.1111/j.1530-0277.2009.01101.x
  42. Tang Y, Banan A, Forsyth CB, Fields JZ, Lau CK, Zhang LJ, Keshavarzian A: Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res 32;355-364, 2008. https://doi.org/10.1111/j.1530-0277.2007.00584.x
  43. Otto EA, Trapp ML, Schulthesis UT, Helou J: NEK8 mutations affect ciliary and centrosomal localization and may cause nepronophthisis. J Am Soc Nephrol 19;587-592, 2008. https://doi.org/10.1681/ASN.2007040490
  44. Pandey P, Brors B, Srivastava PK, Bott A, Boehn SNE, Groene HJ, Gretz N: Microarray-based approach identifies microRNAs and their target functional patterns in polycystic kidney disease. BMC Genomics 9;624, 2008. https://doi.org/10.1186/1471-2164-9-624
  45. Sarnow P, Jopling CL, Norman KL, Schutz S, Wehner KA: MicroRNAs: expression, avoidance and subversion by vertebrate viruses. Nat Rev Microbiol 4;651-659, 2006. https://doi.org/10.1038/nrmicro1473
  46. Xiao B, Liu Z, Li BS, Tang B, Li W, Guo G, Shi Y, Wang F, Wu Y, Tong WD, Guo H, Mao XH, Zou QM: Induction of microRNA-155 during Helicobacter pylori infection and its negative regulatory role in the inflammatory response. J Infect Dis 200;916-925, 2009. https://doi.org/10.1086/605443
  47. Gupta A, Gartner JJ, Sethupathy P, Hatzigeorgiou AG, Fraser NW: Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript. Nature 442; 82-85, 2006. https://doi.org/10.1038/nature04836
  48. Stern-Ginossary N, Elefant N, Zimmermann A, Wolf DG, Saleh N, Biton M, Horwitz E, Prokocimer Z, Prichard M, Hahn G, Goldman-Wohl D, Greenfield C, Yagel S, Hengel H, Altuvia Y, Margalit H, Mandelboim O: Host immune system gene targeting by a viral miRNA. Science 317;376-381, 2007. https://doi.org/10.1126/science.1140956
  49. Song L, Liu H, Gao S, Jiang W, Huang W: Cellular microRNAS inhibit replication of the H1N1 influenza A virus in infected cells. J Virol 84;8849-8860, 2010. https://doi.org/10.1128/JVI.00456-10
  50. Guo W, Li JT, Pan X, Wei L, Wu JY: Candidate Mycobacterium tuberculosis genes targeted by human microRNAs. Protein Cell 1:419-421, 2010. https://doi.org/10.1007/s13238-010-0056-4
  51. Liu Z, Wang X, Jiang J, Cao Z, Yang B, Cheng X:Modulation of T cell cytokine production by miR-144 with elevated expression in patients with pulmonary tuberculosis. Molec Immunol 48;1084-1090, 2011. https://doi.org/10.1016/j.molimm.2011.02.001
  52. De Flora S, Bonanni P: The prevention of infection-associated cancers. Carinogenesis 32;787-795, 2011. https://doi.org/10.1093/carcin/bgr054
  53. Schulte LN, Eulalio A, Mollenkopf HJ, Reinhardt R, Vogel J: Analysis of the host microRNA response to Salmonella uncovers the control of major cytokines by the let-7 family. The EMBOJ 30;1977-1989, 2011. https://doi.org/10.1038/emboj.2011.94
  54. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM: Modulation of miR-155 and miR-125b levels following lipopolysaccharide/ TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 179;5082-5089, 2007. https://doi.org/10.4049/jimmunol.179.8.5082
  55. Orkin SH, Higgs DR: Sickle cell disease at 100 years. Science 329;291-292, 2010. https://doi.org/10.1126/science.1194035
  56. Chen SY, Wang Y, Telen MJ, Chi JT: The genomic analysis of erythrocyte microRNA expression in sickle cell disease. PLoS ONE 3;e2360, 2008. https://doi.org/10.1371/journal.pone.0002360
  57. Sankaran VG, Menne TF, Scepanovic D, Vergillo JA, Ji P, Kim J, Thiru P, Orkin SH, Lander ES, Lodish HF: MicroRNA- 15a and -16-1 act via MYB to elevate fetal hemoglobin expression in human trisomy 13. Proc Natl Acad Sci 108; 1519-1524, 2011. https://doi.org/10.1073/pnas.1018384108
  58. Pan Q, Chegini N: MicroRNA signature and regulatory functions in the endometrium during normal and disease states. Semin Reprod Med 26;479-493, 2008. https://doi.org/10.1055/s-0028-1096128
  59. Germain RN, Meier-Schellersheim M, Nita-Lazar A, Fraser I: Systems biology in immunology: A computational modeling perspective. Ann Rev Immunol 29;527-585, 2011. https://doi.org/10.1146/annurev-immunol-030409-101317
  60. Izzotti A, Calin GA, Arrigo P, Steele VE, Croce CM, De Flora S: Downregulation of microRNA expression in the lungs of rats exposed to cigarette smoke. FASEB J 23;806-812, 2009. https://doi.org/10.1096/fj.08-121384
  61. Liu X, Wang T, Wakita T, Yang W: Systematic identification of microRNA and messenger RNA profiles in hepatitis C virus- infected human hepatoma cells. Virology 398;57-67, 2010. https://doi.org/10.1016/j.virol.2009.11.036
  62. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW, Chang TC, Vivekanandan P, Torbenson M, Clark KR, Mendell JR, Mendell JT: Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137;1005-1017, 2009. https://doi.org/10.1016/j.cell.2009.04.021
  63. Bala S, Marcos M, Szabo G: Emerging role of microRNAs in liver diseases. World Gastroenterol 15;5633-5640, 2009. https://doi.org/10.3748/wjg.15.5633
  64. Hildebrandt F, Zhou W: Nephronophthisis-associated ciliopathies. J Am Soc Nephrol 18;1855-1871, 2007. https://doi.org/10.1681/ASN.2006121344
  65. Witwer KW, Sisk JM, Gama L, Clements JE: MicroRNA regulation of IFN-$\beta$ protein expression: Rapid and sensitive modulation of the innate immune response. J Immunol 184;2369-2376, 2010. https://doi.org/10.4049/jimmunol.0902712
  66. Belair C, Darfeuille F, Staedel C: Helicobacter pylori and gastric cancer: possible role of microRNA in this intimate relationship. Clin Microbiol Infect 15;806-812, 2009. https://doi.org/10.1111/j.1469-0691.2009.02960.x
  67. Zhang GL, Li YX, Zheng SQ, Liu M, Li X, Tang H: Suppression of hepatitis B virus replication by microRNA- 199a-3p and microRNA-210. Antiviral Res 88;169-173, 2010. https://doi.org/10.1016/j.antiviral.2010.08.008
  68. Ura S, Honda M, Yamashita T, Ueda T, Takatori H, Nishino R, Sunakozaka H, Sakai Y, Horimoto K, Kaneko S: Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatol 49;1098-1112, 2009. https://doi.org/10.1002/hep.22749
  69. Pedersen IM, Cheng G, Wieland S, Volinia S, Croce CM, Chisari FV, David M: Interferon modulation of cellular microRNs as an antiviral mechanism. Nature 18;919-922, 2007.
  70. Ohlsson Teague EM, Vand er Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull LM: MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 23;275-275, 2009.
  71. Davidson MR, Larsen JE, Yang IA, Hayward NK, Clarke BE, Duhig EE, Passmore LH, Bowman RV, Fong KM: MicroRNA-218 is deleted and downregulated in lung squamous cell carcinoma. PLoS ONE 5;e12560, 2010. https://doi.org/10.1371/journal.pone.0012560
  72. Cho JH, Gelinas R, Wang K, Eheridge A, Piper MG, Batte K, Dakhallah D, Price J, Bomman D, Zhang S, Marsh C, Galas D: Systems biology of interstitial lung diseases: integration of microRNA expression. BMC Med Genom 4;8, 2011. https://doi.org/10.1186/1755-8794-4-8
  73. Pandit KV, Milosevic J, Kaminski N: MicroRNAs in idiopathic pulmonary fibrosis. Transl Res 157;191-199, 2011. https://doi.org/10.1016/j.trsl.2011.01.012
  74. Bouros D, Nicholson AC, Polychronopoulos V, du Bois RM: Acute interstitial pneumonia. Eur Respir J 15;412-418, 2000. https://doi.org/10.1034/j.1399-3003.2000.15b31.x
  75. Berkhout B, Jeang KT: RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem 282;26641-26645, 2007. https://doi.org/10.1074/jbc.R700023200
  76. Berkhout B, Jeang KT: RISCy business: MicroRNAs, pathogenesis, and viruses. J Biol Chem 282;26641-26645, 2007. https://doi.org/10.1074/jbc.R700023200
  77. Ghosh Z, Mallick B, Chakrabarti J: Cellular versus viral microRNAS in host-virus interaction. Nucl Acids Res 37; 1035-1048, 2009.
  78. Jin WB, Wu FL, Kong D, Guo AG: HBV-encoded microRNA candidate and its target. Comput Biol 31;124-126, 2007.
  79. Lee SO, Masyuk T, Splinter P, Banales JM, Masyuk A, Stroope A, Larusso N: MicroRNA15a modulates expression of the cell-cycle regulator Cdc25A and affects hepatic cystogenesis in a rat model of polycystic kidney disease. J Clin Invest 118;3714-3724, 2008. https://doi.org/10.1172/JCI34922
  80. Chu AS, Firedman JR: A role for microRNA in cystic liver and kidney diseases. J Clin Invest 118;3585-3587, 2008. https://doi.org/10.1172/JCI36870
  81. Wang K, Zhang S, Marzolf B, Troisch P, Brightman A, Hu Z, Hood LE, Galas DJ: Circulating microRNAs, potential biomarker for drug-induced liver injury. Proc Natl Acad Sci 106;4402-4407, 2009. https://doi.org/10.1073/pnas.0813371106
  82. Dolganiuc A, Petrasek J, Kodys K, Catalano D, Mandrekar P, Velayudham A, Szabo O: MicroRNA expression profile in Lieber-DeCarlie diet induced alcoholic and methionine choline deficient diet-induced nonalcoholic steatohepatitis models in mice. Alcohol Clin Exp Res 33;1704-1710, 2009. https://doi.org/10.1111/j.1530-0277.2009.01007.x
  83. Skalsky RL, Cullen BR: Viruses, microRNAs, and host interactions. Annu Rev Microbiol 64;123-141, 2010. https://doi.org/10.1146/annurev.micro.112408.134243
  84. Grundhoff A, Sullivan CS: Virus-encoded microRNAs. Virology 411;325-343, 2011. https://doi.org/10.1016/j.virol.2011.01.002
  85. Grassmann R, Jeang KT: The roles of microRNAs in mammalian virus infection. Biochim Biophys Acta 1779;706-711,2008. https://doi.org/10.1016/j.bbagrm.2008.05.005
  86. Gottwein E, Cullen BR: Viral and cellular microRNAs as determinants of viral pathogenesis and immunity. Cell Host Microbs 3;375-387, 2008. https://doi.org/10.1016/j.chom.2008.05.002
  87. Sonkoly E, Stahle M, Pivarcse A: MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 18;131-140, 2008. https://doi.org/10.1016/j.semcancer.2008.01.005
  88. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, Ju J, John B, Enright AJ, Marks D, Sander C, Tuschl T: Identification of virus-encoded microRNAs. Science 304;734-736, 2004. https://doi.org/10.1126/science.1096781
  89. Pfeffer S, Sewer A, Lagos-Quintana M, Sheridan R, Sander C, Grässer FA, van Dyk LF, Ho CK, Shuman S, Chien M, Russo JJ, Ju J, Randall G, Lindenbach BD, Rice CM, Simon V, Ho DD, Zavolan M, Tuschl T: Identification of microRNAs of the herpesvirus family. Nat Methods 2;269-276, 2005. https://doi.org/10.1038/nmeth746
  90. Sullivan CS, Grundhoff AT, Tevethia S, Pipas JM, Ganem D: SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells. Nature 435; 682-686, 2005. https://doi.org/10.1038/nature03576
  91. Lodish HF, Zhou B, Liu G, Chen CZ: Micromanagement of the immune system by microRNAs. Nat Rev Immunol 8; 120-130, 2008. https://doi.org/10.1038/nri2252
  92. DiChiara JM, Contreras-Martinez LM, Livny J, Smith D, McDonough KA, Belfort M: Multiple small RNAs identified in Mycobacerium bovis BCG are also expressed in Mycobacterium tuberculosis and Mycobacterium smegmatis. Nucleic Acid Res 38;4067-4078, 2010. https://doi.org/10.1093/nar/gkq101
  93. Zhang B, Farwell MA: microRNAs: new emerging class of players for disease diagnosis and gene. J Cell Mol Med 12;3-21, 2008.
  94. Gottwein E, Mukherjee N, Saches C, Frenzel C, Majoros WH, Chi JTA, Braich R, Manoharan M, Soutschek J, Ohler U, Cullen BR: A viral microRNA functions as an ortholog of cellular miR-155. Nature 450;1096-1099, 2007. https://doi.org/10.1038/nature05992
  95. Huang J, Wang F, Argyris E, Chen K, Liang Z, Tian H, Huang W, Squires K, Verlinghieri G, Zhang H: Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes. Nature Med 13;1241-1247, 2007. https://doi.org/10.1038/nm1639
  96. Potenza N, Papa U, Mosca N, Zerbini F, Nobile V, Russo A: Human microRNA hsa-miR-125a-5p interferes with expression of hepatitis B virus surface antigen. Nucleic Acids Res 39;5157-5163, 2011. https://doi.org/10.1093/nar/gkr067
  97. Saba R, Goodman CD, Huzarewich RLCH, Robertson C, Booth SA: A miRNA signature of prion induced neurodegeneration. PLoS ONE 3;e3652, 2008. https://doi.org/10.1371/journal.pone.0003652
  98. Fassi Fehri L, Koch M, Belogolova E, Khalil H, Bolz C, Kalali B, Mollenkopf HJ, Beigier-Bompadre M, Karlas A, Schneider T, Churin Y, Gerhard M, Meyer TF: Helicobacter pylori induces miR-155 in T cells in a cAMP-Foxp3- dependent manner. PLoS One 5;e9500, 2010. https://doi.org/10.1371/journal.pone.0009500
  99. Matsushima K, Isomoto H, Inoue N, Nakayama T, Hayashi T, Nakayama M, Nakao K, Hirayama T, Kohno S: MicroRNA signature in Helicobacter pylori-infected gastric mucosa. Int J Cancer 128;361-370, 2011. https://doi.org/10.1002/ijc.25348
  100. Voinnet O: Micro-balancing innate immunity to Salmonella. The EMBO J 30;1877-1879, 2011. https://doi.org/10.1038/emboj.2011.134

Cited by

  1. Guidelines for the design, analysis and interpretation of ‘omics’ data: focus on human endometrium vol.20, pp.1, 2011, https://doi.org/10.1093/humupd/dmt048
  2. MicroRNAs enrichment in GWAS of complex human phenotypes vol.16, pp.1, 2011, https://doi.org/10.1186/s12864-015-1513-5
  3. Role of microRNA-210 in human intervertebral disc degeneration vol.11, pp.6, 2011, https://doi.org/10.3892/etm.2016.3176
  4. The role of microRNAs in gallbladder cancer vol.5, pp.1, 2011, https://doi.org/10.3892/mco.2016.905
  5. MicroRNAs Modulate Pathogenesis Resulting from Chlamydial Infection in Mice vol.85, pp.1, 2011, https://doi.org/10.1128/iai.00768-16
  6. Identification of microRNAs in acute respiratory distress syndrome based on microRNA expression profile in rats vol.16, pp.3, 2011, https://doi.org/10.3892/mmr.2017.6948
  7. Non-Coding RNAs and Resistance to Anticancer Drugs in Gastrointestinal Tumors vol.8, pp.None, 2018, https://doi.org/10.3389/fonc.2018.00226
  8. miR-21 mediates nickel nanoparticle-induced pulmonary injury and fibrosis vol.14, pp.9, 2011, https://doi.org/10.1080/17435390.2020.1808727
  9. MicroRNA-210 Regulates Endoplasmic Reticulum Stress and Apoptosis in Porcine Embryos vol.11, pp.1, 2011, https://doi.org/10.3390/ani11010221
  10. The Worst Things in Life are Free: The Role of Free Heme in Sickle Cell Disease vol.11, pp.None, 2011, https://doi.org/10.3389/fimmu.2020.561917
  11. Leishmania regulates host macrophage miRNAs expression by engaging transcription factor c‐Myc vol.109, pp.5, 2011, https://doi.org/10.1002/jlb.4ru0920-614r